Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

United States — National Cancer Institute

Tracked across 40 events · 503 articles · First seen May 18, 2025 · Last active Sep 24, 2026

Sentiment
16
Attention
7
Events
40
Relationships
8
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 60
Tech
Impact: Key funder and coordinator of HCMI, strengthening its leadership in cancer research and precision oncology.
Aug 05, 2026 · 6 articles
2 0
Tech
Impact: Led the study, providing scientific evidence linking disinfection byproducts to uterine cancer risk, which may influence future research and regulatory discussions.
Jul 22, 2026 · 6 articles
2 20
Business
Impact: Granted an internal use license to HLA Protein Technologies, facilitating the transfer of TCR-related technology. This aligns with NCI's mission to advance cancer research and may lead to broader adoption of its licensed technologies.
Aug 11, 2026 · 6 articles
2 0
Tech
Impact: Conducted the study; contributes to environmental epidemiology research.
Jul 21, 2026 · 6 articles
6 50
Tech
Impact: United States — National Cancer Institute provided grants supporting the research for MethylScan, demonstrating its commitment to cancer research.
Apr 06, 2026 · 6 articles
4 50
Tech
Impact: The United States — National Cancer Institute provides funding for Qing Zhu's work on the new breast cancer imaging technology.
Apr 06, 2026 · 6 articles
4 60
Tech
Impact: The United States — National Cancer Institute is where Dr. Steven Rosenberg has served as Chief of the Surgery Branch since 1974, providing the institutional support for his foundational work in cancer immunotherapy.
Jun 16, 2026 · 8 articles
6 50
Tech
Impact: The United States — National Cancer Institute partially funded the study, supporting critical cancer research.
May 19, 2026 · 6 articles
3 30
Tech
Impact: Provided funding (R01CA237569, R37CA234006) supporting the research.
Jun 24, 2026 · 7 articles
6 55
Tech
Impact: Collaborating institution; the study may inform its research directions and reinforce its role in cancer research.
Jul 21, 2026 · 20 articles
6 60
Tech
Impact: Major funder of the trial; supports cancer research and may benefit from successful prevention strategies.
Jul 16, 2026 · 21 articles
2 5
Tech
Impact: Provided funding for the research, supporting its mission to advance cancer research.
Aug 20, 2026 · 6 articles
2 5
Business
Cloverleaf Bio, an RNA therapeutics company spun out of Yale University and headquartered in New Haven, Connecticut, closed an upsized and oversubscribed $33 million seed financing round. The round was led by 4BIO Capital and…
Impact: Provided early federal funding through the SBIR/STTR program that was foundational to Cloverleaf's platform development.
Sep 08, 2026 · 6 articles
2 5
Tech
A study led by Dr. Dan Theodorescu at the University of Arizona Cancer Center has found that loss of the Y chromosome (LOY) in men's body tissue may serve as one of the earliest indicators…
Impact: Funded the study, supporting research that could lead to new cancer screening and prevention strategies.
Sep 18, 2026 · 6 articles
4 0
Regulatory
An advisory committee to the United States — Food and Drug Administration voted on Wednesday to recommend approval of Grail Inc.'s Galleri blood test, the first multi-cancer early detection test to reach this stage of…
Impact: Its experts and officials questioned the test's early-detection performance and it funds research on multi-cancer detection feasibility.
Sep 23, 2026 · 18 articles
3 10
Tech
Impact: The United States — National Cancer Institute>>> provides funding for research related to cancer prevention programs, indirectly supporting the advancements reflected in the new guidelines.
May 30, 2026 · 7 articles
4 50
Regulatory
Impact: The United States — National Cancer Institute is one of the existing healthcare institutions in India — Nagpur that will benefit from improved access to radiopharmaceuticals and advanced diagnostic services.
Jun 16, 2026 · 6 articles
3 0
Tech
Impact: Provided funding for the research.
Jul 15, 2026 · 7 articles
2 20
Tech
Impact: Provided a cancer center support grant (P30 CA168524). Supports cancer research; no direct financial impact.
Aug 04, 2026 · 6 articles
0 5
Business
Impact: The United States — National Cancer Institute participated in the panel discussions, indicating potential collaboration in biomedical research.
Aug 24, 2026 · 6 articles
2 0
Domestic
A study by researchers at the Medical University of South Carolina's Hollings Cancer Center, published in JAMA Network Open, found that the proportion of US women aged 21-29 who have never been screened for cervical…
Impact: Provided funding for the study; its data on cancer incidence were used.
Aug 27, 2026 · 6 articles
2 5
Tech
Researchers led by City of Hope developed an investigational liquid biopsy called PANXEON that could detect pancreatic cancer at its earliest, potentially curable stages. The large international study, published in Nature Medicine, tested the blood…
Impact: The United States — National Cancer Institute helped fund the study through grants supporting the research.
Sep 16, 2026 · 6 articles
2 0
Tech
A study published on Sept. 17, 2026 in Science identified the inherited EGFR T790M mutation as a major risk factor for lung cancer, especially in never-smokers. Researchers led by Jaclyn LoPiccolo and Pasi A. Jänne…
Impact: Stephen Chanock of the United States — National Cancer Institute provided expert commentary on the study's implications for screening and risk assessment.
Sep 17, 2026 · 6 articles
4 0
Business
Impact: The United States — National Cancer Institute is sponsoring trials for iadademstat in various hematologic malignancies and solid tumors under a Cooperative Research and Development Agreement with Oryzon Genomics.
May 14, 2026 · 6 articles
2 0
Domestic
Impact: The United States — National Cancer Institute is investigating ivermectin's ability to treat cancer, but their research is preclinical and cannot yet be applied to patients.
May 12, 2026 · 7 articles
4 0
Regulatory
Impact: The United States — National Cancer Institute>>> sponsored the ATOMIC study, which provided the data for Roche>>>'s sBLA filing.
Jun 11, 2026 · 6 articles
2 0
Tech
Impact: Part of NIH that funded the research; aligns with its goals.
Jul 20, 2026 · 6 articles
2 5
Business
Impact: Referenced for recognition of St. Jude's center.
Aug 18, 2026 · 7 articles
7 50
Tech
On August 19, 2026, Moderna and Merck announced that their personalized mRNA cancer vaccine, intismeran autogene, combined with Merck's immunotherapy Pembrolizumab, met its primary and secondary endpoints in a Phase 3 trial involving 1,137 patients…
Impact: The United States — National Cancer Institute provided data on melanoma prevalence and is involved in cancer research. The trial's success could influence its research priorities and funding.
Aug 19, 2026 · 126 articles
2 5
Tech
Researchers at Sanford Burnham Prebys, Mayo Clinic and international collaborators published findings in Nature (journal) on July 29, 2026, revealing a previously unknown mechanism linking dysfunctional mitochondria to chronic age-related inflammation. The study shows that…
Impact: Provided funding for the study.
Aug 20, 2026 · 6 articles
+ 10 more events View on Dashboard
American Cancer Society ↔ United States — National Cancer Institute
American Cancer Society ↔ United States — National Cancer Institute
United States — National Institutes of Health ↔ United States — National Cancer Institute
United States — National Institutes of Health ↔ United States — National Cancer Institute
United States — Food and Drug Administration ↔ United States — National Cancer Institute
United States — Food and Drug Administration ↔ United States — National Cancer Institute
United States ↔ United States — National Cancer Institute
United States ↔ United States — National Cancer Institute
ERGEN INTELLIGENCE
Track United States — National Cancer Institute live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.